Search Results 341-350 of 17864 for Coagulation

1. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases - Mayo Clinic

   unless patients are receiving anti-coagulation therapy. Patients receiving anti-coagulation therapy with an agent such warfarin or heparin are allowed to ...

2. Colonoscopy Clinical Trials - Mayo Clinic Research

   The purpose is to investigate whether a simple additional treatment applied during colonoscopy (called 'soft' coagulation) can reduce the risk of recurrence ...

3. A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma - Mayo Clinic

   Adequate hematological, renal, hepatic, and coagulation laboratory assessments; Written informed consent to participate in this study before the performance ...

4. The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms - Mayo Clinic

   Admission platelet <50,000 or any known hemorrhagic diathesis, coagulation deficiency, or on oral anticoagulant therapy with an INR >3.0; Contraindication to ...

5. Phase 3 Study Of Daraxonrasib (RMC-6236) In Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) - Mayo Clinic

   * Measurable disease per RECIST 1.1. * Adequate organ function (bone marrow, liver, kidney, coagulation) * Documented RAS mutation status, either mutant or ...

6. Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) (VAYHIT1) - Mayo Clinic

   - Prior use of B-cell depleting therapy (e.g., rituximab). - Absolute neutrophil count below 1.0 G/L at randomization - Participants with concurrent coagulation ...

7. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   Screening values of coagulation parameters including platelet count ... Taking anticoagulant medication (warfarin, heparinoids, and direct coagulation ...

8. Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma - Mayo Clinic

   Coagulation: International Normalized Ratio (INR) < 1.5 times normal, activated Partial Thromboplastin Time (aPTT) < 1.5 times normal. Patients receiving ...

9. AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study - Mayo Clinic

   Abnormal coagulation: INR > 1.5 and not correctable;; Presence of a bleeding disorder;; Platelets < 50,000/mm3. Intervening gastric varices or unavoidable ...

10. Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients - Mayo Clinic

    Patient has acceptable coagulation status as indicated by a PT within normal limits (± 15%) and PTT within normal limits (± 15%). Major Exclusion Criteria.